Cite
Atsukawa M, Tsubota A, Shimada N, et al. Effect of native vitamin D3 supplementation on refractory chronic hepatitis C patients in simeprevir with pegylated interferon/ribavirin. Hepatol Res. 2015;46(5):450-8doi: 10.1111/hepr.12575.
Atsukawa, M., Tsubota, A., Shimada, N., Yoshizawa, K., Abe, H., Asano, T., Ohkubo, Y., Araki, M., Ikegami, T., Okubo, T., Kondo, C., Osada, Y., Nakatsuka, K., Chuganji, Y., Matsuzaki, Y., Iwakiri, K., & Aizawa, Y. (2016). Effect of native vitamin D3 supplementation on refractory chronic hepatitis C patients in simeprevir with pegylated interferon/ribavirin. Hepatology research : the official journal of the Japan Society of Hepatology, 46(5), 450-8. https://doi.org/10.1111/hepr.12575
Atsukawa, Masanori, et al. "Effect of native vitamin D3 supplementation on refractory chronic hepatitis C patients in simeprevir with pegylated interferon/ribavirin." Hepatology research : the official journal of the Japan Society of Hepatology vol. 46,5 (2016): 450-8. doi: https://doi.org/10.1111/hepr.12575
Atsukawa M, Tsubota A, Shimada N, Yoshizawa K, Abe H, Asano T, Ohkubo Y, Araki M, Ikegami T, Okubo T, Kondo C, Osada Y, Nakatsuka K, Chuganji Y, Matsuzaki Y, Iwakiri K, Aizawa Y. Effect of native vitamin D3 supplementation on refractory chronic hepatitis C patients in simeprevir with pegylated interferon/ribavirin. Hepatol Res. 2016 Mar;46(5):450-8. doi: 10.1111/hepr.12575. Epub 2015 Sep 17. PMID: 26289410.
Copy
Download .nbib